These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3559033)
1. Preliminary observations on naltrexone for treatment of Alzheimer's type dementia. Tennant FS J Am Geriatr Soc; 1987 Apr; 35(4):369-70. PubMed ID: 3559033 [No Abstract] [Full Text] [Related]
2. Effect of naltrexone on senile dementia of the Alzheimer type. Hyman BT; Eslinger PJ; Damasio AR J Neurol Neurosurg Psychiatry; 1985 Nov; 48(11):1169-71. PubMed ID: 3001233 [TBL] [Abstract][Full Text] [Related]
3. Cognitive effects of high-dose naltrexone in patients with probable Alzheimer's disease. Knopman DS; Hartman M J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1321-2. PubMed ID: 3794740 [No Abstract] [Full Text] [Related]
4. Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease. Pomara N; Roberts R; Rhiew HB; Stanley M; Gershon S Neurobiol Aging; 1985; 6(3):233-6. PubMed ID: 3903533 [TBL] [Abstract][Full Text] [Related]
5. Naltrexone effects in patients with dementia. Read SL Am J Psychiatry; 2010 Oct; 167(10):1278-9. PubMed ID: 20889669 [No Abstract] [Full Text] [Related]
6. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results]. Acierno G Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054 [No Abstract] [Full Text] [Related]
7. Novel pharmacologic approaches to the treatment of senile dementia of the Alzheimer's type (SDAT). Reisberg B; London E; Ferris SH; Anand R; de Leon MJ Psychopharmacol Bull; 1983; 19(2):220-5. PubMed ID: 6346374 [No Abstract] [Full Text] [Related]
8. Treatment of Alzheimer's disease: a cautionary note. Bowen DM; Sims NR; Benton JS; Curzon G; Davison AN; Neary D; Thomas DJ N Engl J Med; 1981 Oct; 305(17):1016. PubMed ID: 7278915 [No Abstract] [Full Text] [Related]
9. Lecithin in the treatment of Alzheimer's disease. Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143 [No Abstract] [Full Text] [Related]
10. Choline in Alzheimer's disease. Renvoize EB; Jerram T N Engl J Med; 1979 Aug; 301(6):330. PubMed ID: 377082 [No Abstract] [Full Text] [Related]
13. Cholinesterase inhibitors and opiate antagonists in patients with Alzheimer's disease. N Engl J Med; 1983 Sep; 309(9):555-6. PubMed ID: 6877328 [No Abstract] [Full Text] [Related]
14. Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. Weiss BL Am J Psychiatry; 1987 Mar; 144(3):386-7. PubMed ID: 3548443 [No Abstract] [Full Text] [Related]
15. Influence of choline on amnesia in early Alzheimer's disease. Signoret JL; Whiteley A; Lhermitte F Lancet; 1978 Oct; 2(8094):837. PubMed ID: 81385 [No Abstract] [Full Text] [Related]
16. Tacrine for senile dementia of Alzheimer's or Lewy body type. Wilcock GK; Scott MI Lancet; 1994 Aug; 344(8921):544. PubMed ID: 7914636 [No Abstract] [Full Text] [Related]
19. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings]. Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644 [No Abstract] [Full Text] [Related]
20. Double blind study of lecithin in patients with Alzheimer's disease. Fisman M; Merskey H; Helmes E; McCready J; Colhoun EH; Rylett BJ Can J Psychiatry; 1981 Oct; 26(6):426-8. PubMed ID: 7028239 [No Abstract] [Full Text] [Related] [Next] [New Search]